542934 Stock Overview
Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Chandra Bhagat Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹102.02 |
| 52 Week High | ₹160.00 |
| 52 Week Low | ₹80.00 |
| Beta | -0.44 |
| 1 Month Change | -3.66% |
| 3 Month Change | -25.94% |
| 1 Year Change | -7.25% |
| 3 Year Change | 119.40% |
| 5 Year Change | n/a |
| Change since IPO | 97.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| 542934 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -11.1% | -0.7% | -1.5% |
| 1Y | -7.3% | 65.7% | 45.0% |
Return vs Industry: 542934 underperformed the Indian Healthcare industry which returned 65.7% over the past year.
Return vs Market: 542934 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| 542934 volatility | |
|---|---|
| 542934 Average Weekly Movement | 16.5% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 542934's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 542934's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1944 | 29 | Hemant Bhagat | www.cbcpharma.com |
Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, neurology, etc. The company also promotes and markets specialty chemicals; and active pharmaceuticals ingredients and its intermediates. It also exports its products.
Chandra Bhagat Pharma Limited Fundamentals Summary
| 542934 fundamental statistics | |
|---|---|
| Market cap | ₹769.75m |
| Earnings (TTM) | ₹11.72m |
| Revenue (TTM) | ₹1.95b |
65.7x
P/E Ratio0.4x
P/S RatioIs 542934 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 542934 income statement (TTM) | |
|---|---|
| Revenue | ₹1.95b |
| Cost of Revenue | ₹1.84b |
| Gross Profit | ₹105.32m |
| Other Expenses | ₹93.61m |
| Earnings | ₹11.72m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.55 |
| Gross Margin | 5.41% |
| Net Profit Margin | 0.60% |
| Debt/Equity Ratio | 62.4% |
How did 542934 perform over the long term?
See historical performance and comparison